344 related articles for article (PubMed ID: 7923210)
1. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
2. Comparative allelotype of early and advanced stage non-small cell lung carcinomas.
Shiseki M; Kohno T; Adachi J; Okazaki T; Otsuka T; Mizoguchi H; Noguchi M; Hirohashi S; Yokota J
Genes Chromosomes Cancer; 1996 Oct; 17(2):71-7. PubMed ID: 8913723
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of allelic imbalances on chromosome 9p in stage I non-small cell lung carcinoma.
Tomizawa Y; Adachi J; Kohno T; Hamada K; Saito R; Noguchi M; Matsuno Y; Hirohashi S; Yamaguchi N; Yokota J
Clin Cancer Res; 1999 May; 5(5):1139-46. PubMed ID: 10353749
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor genes involved in metastasis of lung and colorectal carcinomas.
Yokota J; Ookawa K; Nishikawa R; Sameshima Y
Princess Takamatsu Symp; 1991; 22():71-6. PubMed ID: 1844253
[TBL] [Abstract][Full Text] [Related]
5. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
[TBL] [Abstract][Full Text] [Related]
6. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
7. Deletion mapping of chromosome 2 in human lung carcinoma.
Otsuka T; Kohno T; Mori M; Noguchi M; Hirohashi S; Yokota J
Genes Chromosomes Cancer; 1996 Jun; 16(2):113-9. PubMed ID: 8818658
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
[TBL] [Abstract][Full Text] [Related]
9. [Accumulation of genetic alterations during human tumor progression].
Yokota J; Ookawa K
Gan To Kagaku Ryoho; 1993 Feb; 20(3):321-5. PubMed ID: 8094949
[TBL] [Abstract][Full Text] [Related]
10. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer.
Wick W; Petersen I; Schmutzler RK; Wolfarth B; Lenartz D; Bierhoff E; Hümmerich J; Müller DJ; Stangl AP; Schramm J; Wiestler OD; von Deimling A
Oncogene; 1996 Mar; 12(5):973-8. PubMed ID: 8649814
[TBL] [Abstract][Full Text] [Related]
12. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.
Aoyagi Y; Yokose T; Minami Y; Ochiai A; Iijima T; Morishita Y; Oda T; Fukao K; Noguchi M
Cancer Res; 2001 Nov; 61(21):7950-4. PubMed ID: 11691817
[TBL] [Abstract][Full Text] [Related]
14. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
[TBL] [Abstract][Full Text] [Related]
16. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Genes Chromosomes Cancer; 2000 Mar; 27(3):244-51. PubMed ID: 10679913
[TBL] [Abstract][Full Text] [Related]
17. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of genetic alterations and progression of primary breast cancer.
Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 428-kb homozygously deleted region disrupting the SEZ6L gene at 22q12.1 in a lung cancer cell line.
Nishioka M; Kohno T; Takahashi M; Niki T; Yamada T; Sone S; Yokota J
Oncogene; 2000 Dec; 19(54):6251-60. PubMed ID: 11175339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
